ESC Premium Access

Relation of atrial remodeling to circulating biomarkers of myocardial fibrosis and apoptotic microparticles in patients with atrial fibrillation and heart failure with preserved ejection fraction

Congress Presentation

About the speaker

Associate Professor Mikhail Dzeshka

Grodno State Medical University, Grodno (Belarus)
0 follower

8 more presentations in this session

Equally high detection rates of atrial fibrillation in patients after a TIA and stroke by systematic ECG monitoring with an implanted device: SPIDER-AF study

Speaker: Doctor F. Goss (Munich, DE)

Thumbnail

Non valvular atrial fibrillation, contraindication to anticoagulation or antiplatelet therapy and heart team approach: a single centre experience

Speaker: Doctor A. Graffigna (Trento, IT)

Thumbnail

Effectiveness and safety of apixaban, dabigatran and warfarin compared to rivaroxaban in non-valvular atrial fibrillation; a Norwegian nationwide cohort study

Speaker: Doctor O. Rutherford (Sarpsborg, NO)

Thumbnail

Non-vitamin K antagonist oral anticoagulants are safe and effective alternatives to warfarin across subgroups by renal function: results from Danish registries

Speaker: Doctor A. Nissen Bonde (Gentofte, DK)

Thumbnail

High mortality in atrial fibrillation patients suffering ischemic stroke, intracranial hemorrhage or a gastrointestinal bleed and associations with the preceding antithrombotic treatment

Speaker: Professor P. Hjemdahl (Stockholm, SE)

Thumbnail

Access the full session

Prevention of thromboembolism and atrial remodelling in atrial fibrillation

Speakers: Associate Professor M. Dzeshka, Doctor F. Goss, Doctor A. Graffigna, Doctor O. Rutherford, Doctor A. Nissen Bonde...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations